Dr. Joël Claveau

Dermatologist, Ville de Québec, QC

Dr. Joël Claveau is a dermatologist, specialized in the diagnosis and treatment of Melanoma and Skin Cancers, and an Associate Professor with the Department of Medicine at Laval University where he completed his Medical Study and Internal Medicine training. He did his residency in Dermatology at McGill University and subsequently worked at the Melanoma Clinic at the Royal Victoria Hospital in Montreal, Quebec. He is a diplomat of the American Board of Dermatology and is a member of a number of Medical Societies including the American Academy of Dermatology and the International Dermoscopy Society. He has received awards including
Honorary Member of La Société Française de Dermatologie, the Dermatologist’s Volunteer Award of the Canadian Dermatology Association (CDA) for his work on the prevention of skin cancers and the CDA
Symposium of the year at two occasions (Dermoscopy).

Since 1996, he has been the Director of the Melanoma and Skin Cancer Clinic at Le Centre Hospitalier Universitaire, Hôtel-Dieu de Québec, and worked in
Public Health for the province of Québec especially on the new Tanning Bed Legislation. He participated to the publication of papers in peer-review journals including work on melanoma, skin cancers and sunscreens. He is actively involved in a various Continuing Medical Education events and investigator in many clinical trials on advanced and metastatic melanoma.

3:20 PM - 4:20 PM

FRI Apr 28

The Role of Skin Care in Cancer Therapy-Related Cutaneous Adverse Events for Cancer Patients and Survivors

The CaSMO project aims to improve the quality of life for cancer patients and survivors by offering tools to prevent and manage cutaneous adverse events. These tools aim to support all healthcare providers treating oncology patients, including physicians, nurses, pharmacists, and advanced providers. In this one-hour session, our faculty will review these tools developed to manage skin-related toxicities for cancer patients undergoing radiation, immunotherapy, hormonal therapy, and targeted therapies.